Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz | AI 资讯 | 云织星·工具台

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

查看原文

如页面未自动加载，请开启 JavaScript。